日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials

在 DREAMM-7 和 DREAMM-8 试验中调整 belantamab mafodotin 的剂量以平衡疗效和耐受性

Mateos, María-Victoria; Trudel, Suzanne; Quach, Hang; Robak, Paweł; Beksac, Meral; Pour, Ludek; Hus, Marek; Kim, Kihyun; Zherebtsova, Vera; Delimpasi, Sosana; Jelínek, Tomas; Ward, Christopher; Ho, P Joy; Vorobyev, Vladimir; Pitombeira de Lacerda, Marcelo; Aparecida-Martinez, Gracia; Spicka, Ivan; Radocha, Jakub; Cavo, Michele; Cerchione, Claudio; Fu, Chengcheng; Suzuki, Kazuhito; Rogers, Rachel; Phillips-Jones, Amy; Wang, Zhaohui; Baig, Hena; Wilkes, Jodie; Zhou, Xiaoou L; Lewis, Eric; Eccersley, Lydia; Sule, Neal; Paka, Prani; Opalinska, Joanna B; Mukhopadhyay, Pralay; Hungria, Vania; Dimopoulos, Meletios Athanasios

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

复发/难治性多发性骨髓瘤的来那度胺三联疗法:捷克骨髓瘤研究组的分析

Minarik, Jiri; Pour, Ludek; Latal, Vojtech; Jelinek, Tomas; Straub, Jan; Jungova, Alexandra; Radocha, Jakub; Pavlicek, Petr; Stork, Martin; Pika, Tomas; Krhovska, Petra; Popkova, Tereza; Sedlak, Frantisek; Spicka, Ivan; Jindra, Pavel; Capounova, Vladimira; Maisnar, Vladimir; Hajek, Roman

A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma

ICARIA 研究的简明语言摘要,该研究比较了伊沙妥昔单抗-泊马度胺-地塞米松方案与泊马度胺-地塞米松方案在多发性骨髓瘤患者中的疗效。

Richardson, Paul G; Perrot, Aurore; San-Miguel, Jesus; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A; Huang, Shang-Yi; Minarik, Jir; Cavo, Michele; Prince, H Miles; Anderson, Kenneth C

De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis

降低Teclistamab剂量治疗复发/难治性多发性骨髓瘤:捷克骨髓瘤研究组真实世界证据分析

Stork, Martin; Radocha, Jakub; Mihalyova, Jana; Spicka, Ivan; Pika, Tomas; Jungova, Alexandra; Boichuk, Ivanna; Mensikova, Klara; Straub, Jan; Sedlak, Frantisek; Minarik, Jiri; Krhovska, Petra; Novakova, Denisa; Hornakova, Michaela; Knechtova, Zdenka; Sendlerova, Nela; Dekojova, Tereza; Maisnar, Vladimir; Jelinek, Tomas; Hajek, Roman; Pour, Ludek

Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Magrolimab联合疗法治疗复发/难治性多发性骨髓瘤患者的II期多臂研究的最终结果

Paul, Barry; Minarik, Jiri; Cottini, Francesca; Gasparetto, Cristina; Khouri, Jack; Gandhi, Mitul; Hillengass, Jens; Levy, Moshe; Liedtke, Michaela; Manda, Sudhir; Sandhu, Irwindeep; Sborov, Douglas; Spicka, Ivan; Usmani, Saad; Dong, Mei; Gu, Lin; Leung, Carmen; Doshi, Parul; Chen, Christine; Pour, Ludek

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

ICARIA-MM 和 IKEMA 研究中国际分期系统第二版的分配和验证

Richardson, Paul G; Perrot, Aurore; Mikhael, Joseph; Martin, Thomas; Beksac, Meral; Spicka, Ivan; Capra, Marcelo; D'Agostino, Mattia; Sonneveld, Pieter; Bisht, Kamlesh; Fukao, Taro; Zhang, Rick; Tada, Keisuke; Tekle, Christina; Macé, Sandrine; Klippel, Zandra; van de Velde, Helgi; Moreau, Philippe

Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis

伊沙妥昔单抗-泊马度胺-地塞米松方案与泊马度胺-地塞米松方案治疗复发难治性多发性骨髓瘤患者的疗效比较:最终总生存期分析

Richardson, Paul G; Perrot, Aurore; Miguel, Jesus San; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A; Huang, Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H Miles; Macé, Sandrine; Zhang, Rick; Dubin, Franck; Morisse, Mony Chenda; Anderson, Kenneth C

Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study

melflufen联合daratumumab和地塞米松治疗复发/难治性多发性骨髓瘤的疗效和安全性:来自随机、开放标签、III期LIGHTHOUSE研究的结果

Pour, Luděk; Szarejko, Monika; Bila, Jelena; Schjesvold, Fredrik H; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hájek, Roman; Usenko, Ganna; Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Bakker, Nicolaas A; Richardson, Paul G; Mateos, Maria-Victoria

Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study

接受美洛氟芬和地塞米松治疗的复发/难治性多发性骨髓瘤患者的健康相关生活质量:来自 III 期 OCEAN 研究的分析

Schjesvold, Fredrik H; Ludwig, Heinz; Delimpasi, Sossana; Robak, Pawel; Coriu, Daniel; Tomczak, Waldemar; Pour, Ludek; Spicka, Ivan; Dimopoulos, Meletios-Athanasios; Masszi, Tamas; Chernova, Natalia G; Sandberg, Anna; Thuresson, Marcus; Norin, Stefan; Bakker, Nicolaas A; Mateos, Maria-Victoria; Richardson, Paul G; Sonneveld, Pieter

First person – Meg Watt

第一人称——梅格·瓦特

Kawikova, I; Hakenova, K; Lebedeva, M; Kleteckova, L; Jakob, L; Spicka, V; Wen, L; Spaniel, F; Vales, K